Recalls / Firms / Tailstorm Health INC
Tailstorm Health INC
8 FDA drug recalls on record.
| Date | Class | Drug | Status |
|---|---|---|---|
| 2025-06-02 | Class II | LIDOcaine HCL Sterile Injection, USP, 20 mg/mL, 2%, (200 mg/10 mL), For Infiltration & Ner | Ongoing |
| 2025-06-02 | Class II | KETAmine Hydrochloride Injection, USP, 50 mg/5mL (10 mg/mL), For IM Use or Slow IV Use, 5 | Ongoing |
| 2025-06-02 | Class II | LIDOcaine HCl Injection, USP, 10mg/mL, 1% (100 mg/10mL), 10 mL Sterile Single Dose Vial, R | Ongoing |
| 2025-06-02 | Class II | LIDOcaine HCL Sterile Injection, USP, 100mg/10mL, 1%, (10mg/mL), w/EPINEPHRINE 1:100,000, | Ongoing |
| 2025-06-02 | Class II | KETAmine Hydrochloride Injection, USP, 500mg/5mL, (10mg/mL), For IM or Slow IV Use, 5mL St | Ongoing |
| 2025-06-02 | Class II | BUPIVAcaine HCL Sterile injection, USP w/EPINEPHRINE 1:200,000, 50 mg/10mL, 0.5%, (5mg/mL) | Ongoing |
| 2024-11-06 | Class II | BEVACIZUMAB (AVASTIN)1.25mg/0.05mL, Sterile Injection, 0.5 mL Single-Dose Syringe, Rx Only | Terminated |
| 2024-07-03 | Class II | Lidocaine HCL Injection, USP 2% 200mg/10mL (20mg/mL) and EPINEPHRINE HCl 1:200,000, 10 ml | Ongoing |